These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 6383366
1. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk. Köhler E, Knospe S, Woltanski G, Maciejewski R, Salzsieder C, Rjasanowski I, Strese J, Michaelis D. Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366 [Abstract] [Full Text] [Related]
2. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M. J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213 [Abstract] [Full Text] [Related]
3. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats. Knospe S, Köhler E, Klöting I. Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775 [Abstract] [Full Text] [Related]
4. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients. Köhler E, Knospe S, Hahn HJ, Roemer KG, Diamantstein T. Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806 [Abstract] [Full Text] [Related]
5. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients. Kruschel B, Jahr H, Marx S, Michaelis D. Biomed Biochim Acta; 1984 May; 43(5):635-9. PubMed ID: 6383367 [Abstract] [Full Text] [Related]
6. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro. Köhler E, Knospe S, Rjasanowski I, Michaelis D. Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214 [Abstract] [Full Text] [Related]
7. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes. Köhler E, Knospe S, Besch W, Michaelis D, Rjasanowski I. Exp Clin Endocrinol; 1989 Dec; 94(3):357-62. PubMed ID: 2698355 [Abstract] [Full Text] [Related]
8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity. Schröder D, Wanka H, Hehmke B, Klöting I, Köhler E, Knospe S, Schmidt S. Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197 [Abstract] [Full Text] [Related]
9. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated. Koevary SB. Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881 [Abstract] [Full Text] [Related]
10. Natural killer cell and islet killer cell activities in human type 1 diabetes. Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L, Gupta S, Charles AM. Exp Clin Endocrinol; 1987 Aug; 89(3):345-53. PubMed ID: 3311777 [Abstract] [Full Text] [Related]
11. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro. Schröder D, Hehmke B, Kohnert KD, Fiebach H, Jenssen HL, Besch W. Biomed Biochim Acta; 1985 Aug; 44(1):107-15. PubMed ID: 3888202 [Abstract] [Full Text] [Related]
12. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions. Schröder D, Hehmke B, Klöting I, Besch W. Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813 [Abstract] [Full Text] [Related]
13. The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk. Rjasanowski I, Michaelis D, Dietz H, Witt S, Köhler E, Knospe S. Exp Clin Endocrinol; 1985 Feb; 85(1):70-4. PubMed ID: 3886413 [Abstract] [Full Text] [Related]
14. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats. Hehmke B, Schröder D, Klöting I. Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210 [Abstract] [Full Text] [Related]
15. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells. Koevary SB. Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569 [Abstract] [Full Text] [Related]
16. Immunological events in new onset diabetes. Charles M, Suzuki M, Sundsmo J, Waldeck N, Negishi K, Slater L, Ong K, Buckingham B, Kershnar A. Biomed Biochim Acta; 1984 Jun; 43(5):615-9. PubMed ID: 6383365 [Abstract] [Full Text] [Related]
17. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release. Sadovnikova NV, Pankov YA, Fedotov VP, Czernushkina AV, Zhukovsky MA, Shcherbacheva LN. Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810 [Abstract] [Full Text] [Related]
18. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study. Ziegler B, Klöting I, Besch W, Ziegler M, Hahn HJ. Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954 [Abstract] [Full Text] [Related]
19. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L. Orv Hetil; 1999 Nov 28; 140(48):2695-701. PubMed ID: 10645715 [Abstract] [Full Text] [Related]
20. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro. Kohnert KD, Hehmke B, Fält K, Ziegler M. Biomed Biochim Acta; 1984 Nov 28; 43(5):663-73. PubMed ID: 6206850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]